Expect 50% returns in Glenmark Pharma from current levels in next 12 months time, says Aashish Tater, Head of Research, Fortunewizard.com. We feel the expansion is going to continue even for next 3-4 quarters, which will be very rewarding for these kinds of companies. We have been bullish on Cipla, Glenmark, Wockhardt and we continue to do so.
first published: Nov 15, 2012 09:44 am
A collection of the most-viewed Moneycontrol videos.

SOBO to Bandra: Why Only South Mumbai Residents Call Bandra a Downgrade | The Tenant

Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell

Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell

Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
You are already a Moneycontrol Pro user.

